The US Government has asked drugmakers and fine chemicals firms if laws designed to stop the proliferation of chemical weapons are hurting legitimate business.
The proposed FDA funding for 2009 has given a boost to the agency, with $300m more being offered than the agency requested to ensure the safety of products.
Following Barack Obama’s victory in the race to the White House, in-PharmaTechnologist.com examines what this could mean for the pharmaceutical industry.
US President George W Bush has signed a bill under which counterfeiters can be sentenced to life imprisonment if their crime causes the death of an individual.
New US legislation governing the security of chemical production
plants will come into force on 4 April 2007, with non-compliers
risking daily fines or plant shutdown.
A report on the US Food and Drug Administration's (FDA) enforcement
record by US Democratic lawmakers has highlighted a plunge in the
number of warning letters the agency has sent to drug manufacturers
since 2000, citing several...
The new US Food and Drug Administration (FDA) Commissioner - Andrew
von Eschenbach - has stepped down as director of the National
Cancer Institute after his ability to carry out both roles in
tandem was questioned.
The US Food and Drug Administration (FDA) has found itself once
again without a permanent Commissioner after the current incumbent
- Lester Crawford - resigned after 18 months in the post.
In the US, Altor BioScience has received a phase I Small Business
Innovation Research (SBIR) grant from the National Cancer Institute
(NCI) to support development of its processes for making
therapeutic antibodies in transgenic lettuce.
As reported last week, Mark McClellan looks set to leave his post
as Commissioner of the US Food and Drug Administration (FDA) to run
the agency that oversees Medicare and its new prescription drug
programme for the elderly and disabled.
The cost of implementing the US Medicare Act - which for the first
time provides a prescription drug benefit for the elderly and
disabled - is rising fast and represents a 'cave-in' to the drug
industry by the US government.
The US government's attempt to reform the federal Medicare system
to provide a prescription benefit for the elderly and disabled has
been slammed by the Democrats, who believe it will prevent US
states from negotiating price...
New legislation in the US to give the elderly and disabled rights
to reimbursement for prescription drugs under the federal Medicare
system has been passed by the Senate. It has been estimated that
the measure could expand the revenues...
